Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/30/2025

Treatment of Urethritis with Symptoms but Absent White Blood Cells on First-Void Urine

Diagnostic Confirmation Required

  • The Centers for Disease Control and Prevention (CDC) recommends that urethritis should be confirmed by at least one of the following criteria before initiating treatment: mucopurulent or purulent urethral discharge, Gram stain of urethral secretions showing ≥5 WBCs per oil immersion field, positive leukocyte esterase test on first-void urine, or microscopic examination of first-void urine demonstrating ≥10 WBCs per high-power field 1, 2, 3
  • The CDC guidelines state that if none of these criteria are present, treatment should be deferred, and the patient should be tested for N. gonorrhoeae and C. trachomatis using nucleic acid amplification tests 1, 2, 3

When to Treat Empirically Despite Absent WBCs

  • The CDC recommends empiric treatment without documentation of urethritis only for patients at high risk for infection who are unlikely to return for follow-up evaluation, such as adolescents with multiple partners, and these patients should receive treatment covering both gonorrhea and chlamydia 1, 2, 3
  • The American College of Physicians and the CDC suggest that empiric treatment for high-risk patients can include Azithromycin 1g orally as a single dose or Doxycycline 100mg orally twice daily for 7 days, plus treatment for gonorrhea if gonococcal infection cannot be ruled out 1, 2

If Testing Returns Positive

  • If nucleic acid amplification testing demonstrates infection with either N. gonorrhoeae or C. trachomatis, the CDC recommends appropriate pathogen-directed treatment should be given and sexual partners referred for evaluation and treatment 1, 2, 3

Partner Management

  • The CDC recommends that all sexual partners within the preceding 60 days must be evaluated and treated, and should receive treatment effective against chlamydia regardless of whether a specific pathogen is identified in the index patient 3, 1, 2

Common Pitfalls to Avoid

  • The CDC advises against treating based on symptoms alone without objective evidence of urethritis unless the patient meets high-risk criteria for empiric treatment 1, 2
  • The CDC also recommends ensuring nucleic acid amplification testing is performed rather than relying solely on urine microscopy, as these tests are more sensitive for detecting C. trachomatis and N. gonorrhoeae 3

Follow-Up Considerations

  • The CDC suggests that patients should return for evaluation if symptoms persist or recur after completion of therapy, and consider repeat testing 3-6 months after treatment due to high reinfection rates 1, 2, 5, 6